nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.297	0.426	CbGbCtD
Linagliptin—ABCB1—Colchicine—primary biliary cirrhosis	0.25	0.359	CbGbCtD
Linagliptin—CYP3A4—Colchicine—primary biliary cirrhosis	0.15	0.215	CbGbCtD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.011	0.108	CbGpPWpGaD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00835	0.082	CbGpPWpGaD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00679	0.0666	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—ACE2—primary biliary cirrhosis	0.00602	0.0591	CbGpPWpGaD
Linagliptin—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.0057	0.056	CbGpPWpGaD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00514	0.0505	CbGpPWpGaD
Linagliptin—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00487	0.0242	CcSEcCtD
Linagliptin—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00487	0.0242	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00461	0.023	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00461	0.023	CcSEcCtD
Linagliptin—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.0046	0.0452	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—REN—primary biliary cirrhosis	0.00457	0.0448	CbGpPWpGaD
Linagliptin—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00452	0.0225	CcSEcCtD
Linagliptin—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00452	0.0225	CcSEcCtD
Linagliptin—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00443	0.022	CcSEcCtD
Linagliptin—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00443	0.022	CcSEcCtD
Linagliptin—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00443	0.022	CcSEcCtD
Linagliptin—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00443	0.022	CcSEcCtD
Linagliptin—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0043	0.0214	CcSEcCtD
Linagliptin—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0043	0.0214	CcSEcCtD
Linagliptin—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00399	0.0199	CcSEcCtD
Linagliptin—Malnutrition—Colchicine—primary biliary cirrhosis	0.00385	0.0192	CcSEcCtD
Linagliptin—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00359	0.0179	CcSEcCtD
Linagliptin—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00359	0.0179	CcSEcCtD
Linagliptin—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00358	0.0178	CcSEcCtD
Linagliptin—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00358	0.0178	CcSEcCtD
Linagliptin—Angioedema—Colchicine—primary biliary cirrhosis	0.00352	0.0175	CcSEcCtD
Linagliptin—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00346	0.0172	CcSEcCtD
Linagliptin—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00346	0.0172	CcSEcCtD
Linagliptin—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00335	0.0167	CcSEcCtD
Linagliptin—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00335	0.0167	CcSEcCtD
Linagliptin—Arthralgia—Colchicine—primary biliary cirrhosis	0.00328	0.0163	CcSEcCtD
Linagliptin—Myalgia—Colchicine—primary biliary cirrhosis	0.00328	0.0163	CcSEcCtD
Linagliptin—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.00327	0.0321	CbGpPWpGaD
Linagliptin—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00316	0.0157	CcSEcCtD
Linagliptin—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00316	0.0157	CcSEcCtD
Linagliptin—Skin disorder—Colchicine—primary biliary cirrhosis	0.00305	0.0152	CcSEcCtD
Linagliptin—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00302	0.015	CcSEcCtD
Linagliptin—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00302	0.015	CcSEcCtD
Linagliptin—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00294	0.0147	CcSEcCtD
Linagliptin—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00294	0.0147	CcSEcCtD
Linagliptin—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00294	0.0147	CcSEcCtD
Linagliptin—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00294	0.0147	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00292	0.0146	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00292	0.0146	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00286	0.0143	CcSEcCtD
Linagliptin—DPP4—Peptide hormone metabolism—ACE—primary biliary cirrhosis	0.00285	0.028	CbGpPWpGaD
Linagliptin—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00284	0.0278	CbGpPWpGaD
Linagliptin—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0028	0.014	CcSEcCtD
Linagliptin—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0028	0.014	CcSEcCtD
Linagliptin—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00274	0.0137	CcSEcCtD
Linagliptin—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00274	0.0137	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00271	0.0135	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00257	0.0128	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00257	0.0128	CcSEcCtD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00252	0.0247	CbGpPWpGaD
Linagliptin—Urticaria—Colchicine—primary biliary cirrhosis	0.0025	0.0124	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00244	0.0121	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00244	0.0121	CcSEcCtD
Linagliptin—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00241	0.012	CcSEcCtD
Linagliptin—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00241	0.012	CcSEcCtD
Linagliptin—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00231	0.0115	CcSEcCtD
Linagliptin—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00224	0.0112	CcSEcCtD
Linagliptin—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00224	0.0112	CcSEcCtD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.0022	0.0216	CbGpPWpGaD
Linagliptin—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.00216	0.0212	CbGpPWpGaD
Linagliptin—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00215	0.0107	CcSEcCtD
Linagliptin—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00208	0.0104	CcSEcCtD
Linagliptin—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00208	0.0104	CcSEcCtD
Linagliptin—Rash—Colchicine—primary biliary cirrhosis	0.00198	0.00987	CcSEcCtD
Linagliptin—Dermatitis—Colchicine—primary biliary cirrhosis	0.00198	0.00986	CcSEcCtD
Linagliptin—Headache—Colchicine—primary biliary cirrhosis	0.00197	0.0098	CcSEcCtD
Linagliptin—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00193	0.00962	CcSEcCtD
Linagliptin—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00193	0.00962	CcSEcCtD
Linagliptin—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00181	0.0178	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—AGT—primary biliary cirrhosis	0.00181	0.0177	CbGpPWpGaD
Linagliptin—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00887	CcSEcCtD
Linagliptin—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00887	CcSEcCtD
Linagliptin—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00886	CcSEcCtD
Linagliptin—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00886	CcSEcCtD
Linagliptin—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00881	CcSEcCtD
Linagliptin—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00881	CcSEcCtD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00155	0.0152	CbGpPWpGaD
Linagliptin—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00154	0.0151	CbGpPWpGaD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00152	0.0149	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.00145	0.0142	CbGpPWpGaD
Linagliptin—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.00138	0.0136	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00136	0.0133	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00127	0.0125	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ACE2—primary biliary cirrhosis	0.00114	0.0112	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000936	0.00919	CbGpPWpGaD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000936	0.00918	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000918	0.00901	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000891	0.00875	CbGpPWpGaD
Linagliptin—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000886	0.0087	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—REN—primary biliary cirrhosis	0.000862	0.00846	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.00085	0.00834	CbGpPWpGaD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000844	0.00828	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000827	0.00812	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.000812	0.00797	CbGpPWpGaD
Linagliptin—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000789	0.00774	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—IGFBP1—primary biliary cirrhosis	0.000752	0.00738	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000724	0.0071	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ACE—primary biliary cirrhosis	0.000538	0.00528	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000525	0.00515	CbGpPWpGaD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.00052	0.0051	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000519	0.0051	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000488	0.00479	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.00038	0.00373	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	0.00037	0.00363	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	0.000369	0.00363	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000363	0.00356	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—AGT—primary biliary cirrhosis	0.000341	0.00335	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	0.000336	0.0033	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	0.000282	0.00277	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—MMP2—primary biliary cirrhosis	0.000267	0.00262	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000244	0.0024	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LBR—primary biliary cirrhosis	0.00017	0.00167	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	0.000152	0.00149	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000151	0.00148	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000144	0.00142	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000132	0.0013	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	0.000123	0.00121	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000123	0.00121	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	0.000109	0.00107	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	0.000105	0.00103	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	0.000103	0.00101	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	0.000103	0.00101	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	9.17e-05	0.0009	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	7.57e-05	0.000743	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	6.75e-05	0.000662	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	6.34e-05	0.000623	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	6.34e-05	0.000623	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	6.19e-05	0.000607	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	5.75e-05	0.000565	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	4.93e-05	0.000484	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	4.89e-05	0.00048	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	4.79e-05	0.000471	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	4.22e-05	0.000414	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	4.22e-05	0.000414	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	3.81e-05	0.000374	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	3.76e-05	0.000369	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	3.54e-05	0.000348	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	3.04e-05	0.000298	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	3.01e-05	0.000296	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AGT—primary biliary cirrhosis	2.93e-05	0.000287	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	2.6e-05	0.000255	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	2.6e-05	0.000255	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	2.31e-05	0.000227	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALB—primary biliary cirrhosis	2.25e-05	0.00022	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	1.8e-05	0.000177	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.38e-05	0.000136	CbGpPWpGaD
